1.20
前日終値:
$1.21
開ける:
$1.22
24時間の取引高:
8.52M
Relative Volume:
0.80
時価総額:
$764.30M
収益:
$29.48M
当期純損益:
$-201.19M
株価収益率:
-3.75
EPS:
-0.32
ネットキャッシュフロー:
$-216.50M
1週間 パフォーマンス:
+5.73%
1か月 パフォーマンス:
-16.08%
6か月 パフォーマンス:
-60.26%
1年 パフォーマンス:
-73.39%
Geron Corp Stock (GERN) Company Profile
名前
Geron Corp
セクター
電話
(650) 473-7700
住所
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
GERN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
GERN
Geron Corp
|
1.20 | 770.67M | 29.48M | -201.19M | -216.50M | -0.32 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 60.58B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 54.99B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
674.90 | 42.25B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.93B | 3.81B | -644.79M | -669.77M | -6.24 |
Geron Corp Stock (GERN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-10 | 再開されました | Goldman | Sell |
2025-05-08 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
2025-02-27 | ダウングレード | B. Riley Securities | Buy → Neutral |
2025-02-26 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2024-11-05 | 開始されました | H.C. Wainwright | Buy |
2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
2024-09-09 | 開始されました | Leerink Partners | Outperform |
2024-04-30 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2024-04-29 | 開始されました | TD Cowen | Buy |
2024-03-15 | 繰り返されました | Needham | Buy |
2023-09-12 | アップグレード | Goldman | Neutral → Buy |
2023-03-28 | 開始されました | Goldman | Neutral |
2022-10-28 | 開始されました | Wedbush | Outperform |
2022-07-28 | 再開されました | B. Riley Securities | Buy |
2021-11-02 | 開始されました | Robert W. Baird | Outperform |
2021-02-18 | 再開されました | B. Riley Securities | Buy |
2020-08-03 | 開始されました | Stifel | Buy |
2019-11-19 | 再開されました | B. Riley FBR | Buy |
2019-09-03 | 開始されました | H.C. Wainwright | Buy |
2019-08-15 | 開始されました | Cantor Fitzgerald | Overweight |
2019-04-09 | アップグレード | Needham | Hold → Buy |
2019-01-31 | アップグレード | B. Riley FBR | Neutral → Buy |
2018-10-02 | ダウングレード | B. Riley FBR | Buy → Neutral |
2018-07-05 | 開始されました | B. Riley FBR, Inc. | Buy |
2016-09-13 | 繰り返されました | FBR & Co. | Outperform |
2016-09-13 | 繰り返されました | FBR Capital | Outperform |
2015-12-07 | 繰り返されました | Piper Jaffray | Overweight |
2015-04-21 | 開始されました | Oppenheimer | Outperform |
2014-06-12 | アップグレード | MLV & Co | Hold → Buy |
2014-03-12 | ダウングレード | MLV & Co | Buy → Hold |
2013-12-10 | 繰り返されました | MLV & Co | Buy |
2013-12-10 | アップグレード | Needham | Hold → Buy |
2013-11-08 | 繰り返されました | MLV & Co | Buy |
2013-10-16 | 開始されました | MLV & Co | Buy |
2012-08-30 | 開始されました | Stifel Nicolaus | Buy |
2012-06-28 | 開始されました | Needham | Hold |
すべてを表示
Geron Corp (GERN) 最新ニュース
Geron: Q2 Earnings Snapshot - San Antonio Express-News
Geron earnings beat, revenue topped estimates - Investing.com
Geron appoints Harout Semerjian as new CEO amid RYTELO expansion - Investing.com
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Stock Titan
What is the dividend policy of Geron Corporation stockUnlock daily trading alerts for profits - Jammu Links News
What makes Geron Corporation stock price move sharplyExtraordinary earning power - Jammu Links News
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) With a $3 PT - Insider Monkey
Commercial Stage Biotech Geron Sets Q2 Earnings Release: Key Financial Updates Coming August 6 - Stock Titan
How high can Geron Corporation stock price go in 2025Real Time Stock Signal - metal.it
What is the risk reward ratio of investing in Geron Corporation stockGet timely market insights for better trades - Jammu Links News
How volatile is Geron Corporation stock compared to the marketDynamic growth stocks - Jammu Links News
Geron (GERN.O) Surges 5.08%: What’s Driving the Intraday Rally? - AInvest
What analysts say about Geron Corporation stockOutstanding stock performance - jammulinksnews.com
Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN) - simplywall.st
Geron Corporation Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com
Geron Corporation (GERN) Plunges 3.88% to 2025 Low on Earnings Miss - AInvest
Commercial Stage Biotech Geron Expands Team with 342,000 Share Equity Package for Strategic New Hires - Stock Titan
Why Geron Corporation stock attracts strong analyst attentionTechnical Breakout List - Newser
Geron Presents Positive RYTELO Data for LR-MDS at ASCO & EHA, Highlights Efficacy, Myelofibrosis Program Progress - Insider Monkey
Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Geron (NASDAQ:GERN) Shares Gap Down – Here’s Why - Defense World
Cambridge Investment Research Advisors Inc. Cuts Stock Position in Geron Corporation (NASDAQ:GERN) - Defense World
Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today - MSN
Geron resumed with a Sell at Goldman Sachs - TipRanks
Geron Corp’s Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating - TipRanks
Goldman Sachs resumes Geron stock coverage with Sell rating on weak Rytelo sales - Investing.com
Geron Corp (GERN) Stock: A Year of Highs and Lows - investchronicle.com
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) - MSN
13 Stocks Under $5 With High Upside Potential - Insider Monkey
DSS switches auditors to HTL; no disputes with Grassi reported | GERN SEC FilingForm 4 - Stock Titan
Geron Corporation(NasdaqGS: GERN) dropped from Russell 2500 Value Index - MarketScreener
Geron Corporation(NasdaqGS: GERN) dropped from Russell Small Cap Comp Value Index - MarketScreener
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Expands Team with 16 New Hires, Awards Over $1.6M in Stock Options and RSUs - Stock Titan
With 65% institutional ownership, Geron Corporation (NASDAQ:GERN) is a favorite amongst the big guns - Yahoo Finance
Geron: A Tough First Year For Rytelo, But Not Yet Time To Sell (Downgrade) (NASDAQ:GERN) - Seeking Alpha
Favourable Signals For Geron: Numerous Insiders Acquired Stock - simplywall.st
Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges - Investing.com
Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges By Investing.com - Investing.com Canada
Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights - mx.advfn.com
Class Action Filed Against Geron Corporation (GERN)May 12, 2025 Deadline to JoinContact The Gross Law Firm - mx.advfn.com
Conservative Vision Of A Positive Future For Geron (NASDAQ:GERN) - Seeking Alpha
Is Geron Corporation Stock a Bargain Now? - StocksToTrade
Nuveen Asset Management LLC Purchases 14,657 Shares of Geron Co. (NASDAQ:GERN) - Defense World
Geron showcases RYTELO benefits at oncology meetings By Investing.com - Investing.com South Africa
Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles By Investing.com - Investing.com South Africa
Geron showcases RYTELO benefits at oncology meetings - Investing.com
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program - Yahoo Finance
Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles - Investing.com
Geron Corp stockholders approve equity plan amendments By Investing.com - Investing.com India
Geron Corp stockholders approve equity plan amendments - Investing.com
Geron Corp (GERN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):